| Oct 15 |
Cancer Drugs Propel J&J Beyond Wall Street Estimates
|
| Oct 15 |
Jim Cramer Says ‘Is It The Beginning Of The End Of Johnson & Johnson (JNJ)’s Multi-Year Legal overhang? Could Be’
|
| Oct 15 |
JNJ releases positive data on nipocalimab for myasthenia gravis in adolescents
|
| Oct 15 |
This is the 3-point checklist for healthcare earnings: Strategist
|
| Oct 15 |
Johnson & Johnson (JNJ) Q3 2024 Earnings Call Transcript
|
| Oct 15 |
Top Midday Stories: UnitedHealth Narrows Full-Year Earnings Outlook; Nvidia, AMD May Face Country-Specific Export Caps on AI Chips
|
| Oct 15 |
J&J Beats on Q3 Earnings, Raises Sales View but Cuts EPS Guidance
|
| Oct 15 |
Stocks to Watch Tuesday: J&J, United Health, Apple, Walgreens
|
| Oct 15 |
J&J Reports Strong Earnings, Grapples with Ongoing Legal Challenges
|
| Oct 15 |
Earnings Data Deluge
|
